<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36748375</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1672-7347</ISSN><JournalIssue CitedMedium="Print"><Volume>47</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>28</Day></PubDate></JournalIssue><Title>Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences</Title><ISOAbbreviation>Zhong Nan Da Xue Xue Bao Yi Xue Ban</ISOAbbreviation></Journal><ArticleTitle>Levels of base excision repair proteins in CD4<sup>+</sup> T cells in patients with systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1655</StartPage><EndPage>1662</EndPage><MedlinePgn>1655-1662</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.11817/j.issn.1672-7347.2022.210485</ELocationID><ELocationID EIdType="pii" ValidYN="Y">1672-7347(2022)12-1655-08</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Systemic lupus erythematosus (SLE) is a multi-systemic disease with the unknown pathogenic mechanism. DNA demethylation is involved in SLE pathogenesis. Growth arrest and DNA damage inducible 45 alpha (Gadd45a) takes part in the process of DNA demethylation. Gadd45a is a DNA repair-related protein. This study aims to investigate the expressions of some proteins [including activation-induced cytidine deaminase (AID), thymine DNA glycosylase (TDG), and methyl-CpG-binding domain protein 4 (MBD4)] involving in base excision repair (BER) process in CD4<sup>+</sup> T cells in patients with SLE, and to analyze the correlations between the above BER proteins and lupus disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From January 2019 to September 2020, 12 SLE patients and 12 healthy controls were recruited from Second Xiangya Hospital of Central South University. Peripheral blood mononuclear cells (PBMCs) were separated by Ficoll-Hypaque density gradient centrifugation and then CD4+ T cells were isolated via positive selection using Miltenyi beads. We measured the messenger RNA (mRNA) and protein expressions of AID, TDG, and MBD4 by real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blotting, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In contrast to controls, in SLE CD4+ T cells, the mRNA and protein expressions of AID were elevated (P=0.003, P=0.022, respectively); TDG protein expression was increased (P=0.017); and MBD4 protein level was reduced (P&lt;0.001). No visible distinctions was found in the mRNA expressions of either TDG or MBD4 between the 2 groups (both P&gt;0.05). The mRNA and protein expressions of AID and the protein levels of TDG were positively correlated with SLE disease activity index (SLEDAI). And the mRNA and protein expressions of MBD4 were negatively correlated with SLEDAI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In SLE CD4+ T cells, the increased expressions of AID and TDG and the decreased MBD4 expression may participate in SLE pathogenic mechanism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics; Second Xiangya Hospital, Central South University, Changsha 410011. zxy1994328@csu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaoqi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Changsha Central Hospital, University of South China, Changsha 410000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics; Second Xiangya Hospital, Central South University, Changsha 410011.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yueqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics; Second Xiangya Hospital, Central South University, Changsha 410011.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shengnan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics; Second Xiangya Hospital, Central South University, Changsha 410011.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yaping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics; Second Xiangya Hospital, Central South University, Changsha 410011. lyplisa@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>81472881</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x60a3;&#x8005;CD4<sup>+</sup> T&#x7ec6;&#x80de;&#x78b1;&#x57fa;&#x5207;&#x9664;&#x4fee;&#x590d;&#x86cb;&#x767d;&#x6c34;&#x5e73;&#xff08;&#x82f1;&#x6587;&#xff09;.</VernacularTitle></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhong Nan Da Xue Xue Bao Yi Xue Ban</MedlineTA><NlmUniqueID>101230586</NlmUniqueID><ISSNLinking>1672-7347</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="Y">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;</b>: &#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;(systemic lupus erythematosus&#xff0c;SLE)&#x662f;&#x4e00;&#x79cd;&#x591a;&#x7cfb;&#x7edf;&#x75be;&#x75c5;&#xff0c;&#x5176;&#x53d1;&#x75c5;&#x673a;&#x5236;&#x5c1a;&#x4e0d;&#x6e05;&#x695a;&#x3002;DNA&#x53bb;&#x7532;&#x57fa;&#x5316;&#x53c2;&#x4e0e;SLE&#x7684;&#x53d1;&#x75c5;&#x673a;&#x5236;&#xff0c;&#x751f;&#x957f;&#x505c;&#x6ede;&#x548c;DNA&#x635f;&#x4f24;&#x8bf1;&#x5bfc;&#x578b;45&#x3b1;(Gadd45a)&#x53c2;&#x4e0e;DNA&#x7684;&#x53bb;&#x7532;&#x57fa;&#x5316;&#x8fc7;&#x7a0b;&#x3002;Gadd45a&#x662f;&#x4e00;&#x79cd;DNA&#x4fee;&#x590d;&#x76f8;&#x5173;&#x86cb;&#x767d;&#xff0c;&#x56e0;&#x6b64;&#xff0c;&#x672c;&#x7814;&#x7a76;&#x65e8;&#x5728;&#x5206;&#x6790;&#x53c2;&#x4e0e;&#x78b1;&#x57fa;&#x5207;&#x9664;&#x4fee;&#x590d;(base excision repair&#xff0c;BER)&#x8fc7;&#x7a0b;&#x7684;&#x4e00;&#x4e9b;&#x86cb;&#x767d;&#x8d28;&#xff0c;&#x5305;&#x62ec;&#x6d3b;&#x5316;&#x8bf1;&#x5bfc;&#x80de;&#x5627;&#x5576;&#x8131;&#x6c28;&#x57fa;&#x5316;&#x9176;(activation-induced cytidine deaminase&#xff0c;AID)&#x3001;&#x80f8;&#x817a;&#x5627;&#x5576;DNA&#x7cd6;&#x57fa;&#x5316;&#x9176;(thymine DNA glycosylase&#xff0c;TDG)&#x548c;&#x7532;&#x57fa;CpG&#x7ed3;&#x5408;&#x86cb;&#x767d;4(methyl-CpG-binding domain protein 4&#xff0c;MBD4)&#x5728;SLE&#x60a3;&#x8005;CD4<sup>+</sup> T&#x7ec6;&#x80de;&#x4e2d;&#x7684;&#x8868;&#x8fbe;&#xff0c;&#x5e76;&#x5206;&#x6790;&#x8fd9;&#x4e9b;BER&#x86cb;&#x767d;&#x4e0e;SLE&#x6d3b;&#x52a8;&#x4e4b;&#x95f4;&#x7684;&#x76f8;&#x5173;&#x6027;&#x3002;<b>&#x65b9;&#x6cd5;</b>: 2019&#x5e74;1&#x6708;&#x81f3;2020&#x5e74;9&#x6708;&#x4e2d;&#x5357;&#x5927;&#x5b66;&#x6e58;&#x96c5;&#x4e8c;&#x533b;&#x9662;&#x6536;&#x96c6;12&#x4f8b;SLE&#x60a3;&#x8005;&#x548c;12&#x4f8b;&#x5065;&#x5eb7;&#x4f53;&#x68c0;&#x8005;(&#x5bf9;&#x7167;&#x7ec4;)&#x3002;&#x91c7;&#x7528;Ficoll-Hypaque&#x5bc6;&#x5ea6;&#x68af;&#x5ea6;&#x79bb;&#x5fc3;&#x6cd5;&#x5206;&#x79bb;&#x5916;&#x5468;&#x8840;&#x5355;&#x4e2a;&#x6838;&#x7ec6;&#x80de;(peripheral blood mononuclear cells&#xff0c;PBMCs)&#xff0c;CD4&#x514d;&#x75ab;&#x78c1;&#x73e0;&#x5206;&#x79bb;&#x5916;&#x5468;&#x8840;CD4<sup>+</sup> T&#x7ec6;&#x80de;&#x3002;&#x901a;&#x8fc7;&#x5b9e;&#x65f6;&#x53cd;&#x8f6c;&#x5f55;&#x805a;&#x5408;&#x9176;&#x94fe;&#x53cd;&#x5e94;(real-time RT-PCR)&#x548c;&#x86cb;&#x767d;&#x8d28;&#x5370;&#x8ff9;&#x6cd5;&#x68c0;&#x6d4b;AID&#x3001;TDG&#x548c;MBD4&#x4fe1;&#x4f7f;RNA(mRNA)&#x548c;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x8fbe;&#x6c34;&#x5e73;&#x3002;<b>&#x7ed3;&#x679c;</b>: &#x4e0e;&#x5bf9;&#x7167;&#x7ec4;&#x76f8;&#x6bd4;&#xff0c;SLE&#x60a3;&#x8005;CD4<sup>+</sup> T&#x7ec6;&#x80de;&#x4e2d;<i>AID</i> mRNA&#x548c;&#x86cb;&#x767d;&#x8d28;&#x8868;&#x8fbe;&#x5347;&#x9ad8;(<i>P</i>=0.003&#xff0c;<i>P</i>=0.022)&#x3002;SLE&#x60a3;&#x8005;&#x7684;CD4<sup>+</sup> T&#x7ec6;&#x80de;&#x4e2d;TDG&#x86cb;&#x767d;&#x8868;&#x8fbe;&#x5347;&#x9ad8;(<i>P</i>=0.017)&#xff0c;MBD4&#x86cb;&#x767d;&#x8d28;&#x8868;&#x8fbe;&#x964d;&#x4f4e;(<i>P</i>&lt;0.001)&#x3002;&#x4e24;&#x7ec4;&#x4e4b;&#x95f4;<i>TDG</i>&#x548c;<i>MBD4</i> mRNA&#x8868;&#x8fbe;&#x6c34;&#x5e73;&#x6ca1;&#x6709;&#x660e;&#x663e;&#x5dee;&#x5f02;(&#x5747;<i>P</i>&gt;0.05)&#x3002;<i>AID</i> mRNA&#x548c;&#x86cb;&#x767d;&#x6c34;&#x5e73;&#x53ca;TDG&#x86cb;&#x767d;&#x6c34;&#x5e73;&#x4e0e;&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x75be;&#x75c5;&#x6d3b;&#x52a8;&#x5ea6;(SLE disease activity index&#xff0c;SLEDAI)&#x5448;&#x6b63;&#x76f8;&#x5173;&#xff0c;<i>MBD4</i> mRNA&#x548c;&#x86cb;&#x767d;&#x6c34;&#x5e73;&#x4e0e;SLEDAI&#x5448;&#x8d1f;&#x76f8;&#x5173;&#x3002;<b>&#x7ed3;&#x8bba;</b>: SLE&#x60a3;&#x8005;CD4<sup>+</sup> T&#x7ec6;&#x80de;&#x4e2d;AID&#x548c;TDG&#x8868;&#x8fbe;&#x589e;&#x52a0;&#xff0c;MBD4&#x8868;&#x8fbe;&#x964d;&#x4f4e;&#xff0c;&#x5b83;&#x4eec;&#x53ef;&#x80fd;&#x53c2;&#x4e0e;&#x4e86;SLE&#x7684;&#x53d1;&#x75c5;&#x673a;&#x5236;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA demethylation</Keyword><Keyword MajorTopicYN="N">base excision repair</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36748375</ArticleId><ArticleId IdType="doi">10.11817/j.issn.1672-7347.2022.210485</ArticleId><ArticleId IdType="pii">1672-7347(2022)12-1655-08</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, et al. New insights into the immunopathogenesis of systemic lupus erythematosus[J]. Nat Rev Rheumatol, 2016, 12(12): 716- 730. https://doi.org/10. 1038/nrrheum.2016.186.</Citation></Reference><Reference><Citation>Santulli-Marotto S, Retter MW, Gee R, et al. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens[J]. Immunity, 1998, 8(2): 209- 219. https://doi.org/10.1016/s1074-7613(00)80473-2.</Citation></Reference><Reference><Citation>Li YP, Zhao M, Yin H, et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells[J]. Arthritis Rheum, 2010, 62(5): 1438- 1447. https://doi.org/10.1002/art.27363.</Citation></Reference><Reference><Citation>Niehrs C, Sch&#xe4;fer A. Active DNA demethylation by Gadd45 and DNA repair[J]. Trends Cell Biol, 2012, 22(4): 220- 227. https://doi.org/10.1016/j.tcb.2012.01.002.</Citation></Reference><Reference><Citation>Rai K, Huggins IJ, James SR, et al. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45[J]. Cell, 2008, 135(7): 1201- 1212. https://doi.org/10.1016/j.cell.2008.11.042.</Citation></Reference><Reference><Citation>Cortellino S, Xu JF, Sannai M, et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair[J]. Cell, 2011, 146(1): 67- 79. https://doi.org/10.1016/j.cell.2011.06.020.</Citation></Reference><Reference><Citation>Li Z, Gu TP, Weber AR, et al. gadd45a promotes DNA demethylation through TDG[J]. Nucleic Acids Res, 2015, 43(8): 3986- 3997. https://doi.org/10.1093/nar/gkv283.</Citation></Reference><Reference><Citation>Jung HJ, Kim EH, Mun JY, et al. Base excision DNA repair defect in Gadd45a-deficient cells[J]. Oncogene, 2007, 26(54): 7517- 7525. https://doi.org/10.1038/sj.onc.1210557.</Citation></Reference><Reference><Citation>Senejani AG, Liu YF, Kidane D, et al. Mutation of POLB causes lupus in mice[J]. Cell Rep, 2014, 6(1): 1- 8. https://doi.org/10.1016/j.celrep.2013.12.017.</Citation></Reference><Reference><Citation>Paluri SL, Burak M, Senejani AG, et al. DNA glycosylase deficiency leads to decreased severity of lupus in the Polb-Y265C mouse model[J]. DNA Repair (Amst), 2021, 105: 103152. https://doi.org/10.1016/j.dnarep.2021.103152.</Citation></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40(9): 1725. https://doi.org/10.1002/art.1780400928.</Citation></Reference><Reference><Citation>Liang MH, Socher SA, Larson MG, et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus[J]. Arthritis Rheum, 1989, 32(9): 1107- 1118. https://doi.org/10.1002/anr.1780320909.</Citation></Reference><Reference><Citation>Lo MS, Tsokos GC. Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy[J]. Curr Opin Rheumatol, 2018, 30(2): 222- 228. https://doi.org/10.1097/BOR.0000000000000474.</Citation></Reference><Reference><Citation>Ohnishi T, Mori E, Takahashi A. DNA double-strand breaks: their production, recognition, and repair in eukaryotes[J]. Mutat Res, 2009, 669(1/2): 8- 12. https://doi.org/10.1016/j.mrfmmm.2009.06.010.</Citation></Reference><Reference><Citation>Sirbu BM, Cortez D. DNA damage response: three levels of DNA repair regulation[J]. Cold Spring Harb Perspect Biol, 2013, 5(8): a012724. https://doi.org/10.1101/cshperspect.a012724.</Citation></Reference><Reference><Citation>Meas R, Burak MJ, Sweasy JB. DNA repair and systemic lupus erythematosus[J]. DNA Repair (Amst), 2017, 56: 174- 182. https://doi.org/10.1016/j.dnarep.2017.06.020.</Citation></Reference><Reference><Citation>Bochtler M, Kolano A, Xu GL. DNA demethylation pathways: additional players and regulators[J]. Bioessays, 2017, 39(1): 1- 13. https://doi.org/10.1002/bies.201600178.</Citation></Reference><Reference><Citation>Morgan HD, Dean W, Coker HA, et al. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming[J]. J Biol Chem, 2004, 279(50): 52353- 52360. https://doi.org/10.1074/jbc.M407695200.</Citation></Reference><Reference><Citation>Ying Y, Zhao GQ. Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse[J]. Dev Biol, 2001, 232(2): 484- 492. https://doi.org/10.1006/dbio.2001.0173.</Citation></Reference><Reference><Citation>Sjolund AB, Senejani AG, Sweasy JB. MBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological roles[J]. Mutat Res, 2013, 743/744: 12- 25. https://doi.org/10.1016/j.mrfmmm.2012.11.001.</Citation></Reference><Reference><Citation>Ballestar E, Wolffe AP. Methyl-CpG-binding proteins. Targeting specific gene repression[J]. Eur J Biochem, 2001, 268(1): 1- 6. https://doi.org/10.1046/j.1432-1327.2001.01869.x.</Citation></Reference><Reference><Citation>J&#xf8;rgensen HF, Adie KR, Chaubert P, et al. Engineering a high-affinity methyl-CpG-binding protein[J/OL]. Nucleic Acids Res, 2006, 34(13): e 96[ 2021-03-02]. https://doi.org/10.1093/nar/gkl527.</Citation></Reference><Reference><Citation>Hendrich B, Hardeland U, Ng HH, et al. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites[J]. Nature, 1999, 401(6750): 301- 304. https://doi.org/10.1038/45843.</Citation></Reference><Reference><Citation>Kaga H, Komatsuda A, Omokawa A, et al. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-&#x3b1; in PBMCs from patients with SLE[J]. Mod Rheumatol, 2015, 25(6): 865- 870. https://doi.org/10.3109/14397595.2015.1030102.</Citation></Reference><Reference><Citation>Jiang CC, Foley J, Clayton N, et al. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice[J]. J Immunol, 2007, 178(11): 7422- 7431. https://doi.org/10.4049/jimmunol.178.11.7422.</Citation></Reference><Reference><Citation>Jiang CC, Zhao ML, Diaz M. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis[J]. Immunology, 2009, 126(1): 102- 113. https://doi.org/10.1111/j.1365-2567.2008.02882.x.</Citation></Reference><Reference><Citation>Peng B, Hurt EM, Hodge DR, et al. DNA hypermethylation and partial gene silencing of human thymine-DNA glycosylase in multiple myeloma cell lines[J]. Epigenetics, 2006, 1(3): 138- 145. https://doi.org/10.4161/epi.1.3.2938.</Citation></Reference><Reference><Citation>Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation[J]. Nature, 2013, 502(7472): 472- 479. https://doi.org/10.1038/nature12750.</Citation></Reference><Reference><Citation>He YF, Li BZ, Li Z, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA[J]. Science, 2011, 333(6047): 1303- 1307. https://doi.org/10. 1126/science.1210944.</Citation></Reference><Reference><Citation>Maiti A, Drohat AC. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites[J]. J Biol Chem, 2011, 286(41): 35334- 35338. https://doi.org/10.1074/jbc.C111.284620.</Citation></Reference><Reference><Citation>Kienh&#xf6;fer S, Musheev MU, Stapf U, et al. GADD45a physically and functionally interacts with TET1[J]. Differentiation, 2015, 90(1/2/3): 59- 68. https://doi.org/10.1016/j.diff.2015.10.003.</Citation></Reference><Reference><Citation>Zhao M, Wang J, Liao W, et al. Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus[J]. J Autoimmun, 2016, 69: 64- 73. https://doi.org/10.1016/j.jaut.2016.03.001.</Citation></Reference><Reference><Citation>Wu HJ, Huang X, Qiu H, et al. High salt promotes autoimmunity by TET2-induced DNA demethylation and driving the differentiation of Tfh cells[J]. Sci Rep, 2016, 6: 28065. https://doi.org/10.1038/srep28065.</Citation></Reference><Reference><Citation>Balada E, Ordi-Ros J, Vilardell-Tarr&#xe9;s M. DNA methylation and systemic lupus erythematosus[J]. Ann N Y Acad Sci, 2007, 1108: 127- 136. https://doi.org/10.1196/annals.1422.015.</Citation></Reference><Reference><Citation>Lei W, Luo Y, Lei W, et al. Abnormal DNA methylation in CD4<sup>+</sup> T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis[J]. Scand J Rheumatol, 2009, 38(5): 369- 374. https://doi.org/10.1080/03009740902758875.</Citation></Reference><Reference><Citation>Liao W, Li MY, Wu HJ, et al. Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4<sup>+</sup> T cells in systemic lupus erythematosus[J]. Clin Epigenetics, 2017, 9: 104. https://doi.org/10.1186/s13148-017-0405-8.</Citation></Reference><Reference><Citation>de Sousa Abreu R, Penalva LO, Marcotte EM, et al. Global signatures of protein and mRNA expression levels[J]. Mol Biosyst, 2009, 5(12): 1512- 1526. https://doi.org/10.1039/b908315d.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>